Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Thomas

Showing results (61-70 of 217) with videos related to

Pageof 22
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2021
Germline PALB2 Variants and PARP Inhibitors in Endometrial CancerMichael A Cilento, Nicola K Poplawski, Sellvakumaram Paramasivam, et al.
Cancer Metastasis Reviews|September 11, 2007
RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancerJonathan C M Clark, David M Thomas, Peter F M Choong, et al.
Inhalation Toxicology|January 9, 2013
Tobacco smoke modulates ozone-induced toxicity in rat lungs and central nervous systemVanitha Bhoopalan, Sung Gu Han, Mrudang M Shah, et al.
Pharmacology & Therapeutics|August 22, 2012
Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcomaFergal C Kelleher, Jason E Cain, Joan M Healy, et al.
Oncoimmunology|December 18, 2012
Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcomaChristophe Paget, Helene Duret, Shin Foong Ngiow, et al.
Clinical Sarcoma Research|December 11, 2013
Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective reviewJeremy Lewin, Samantha Wieringa, Marnie Collins, et al.
Asia-Pacific Journal of Clinical Oncology|March 1, 2016
International survey of awareness of genetic risk in the clinical sarcoma communityKate A McBride, Timothy E Schlub, Mandy L Ballinger, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 28, 2004
Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activationDavid M Thomas, Paul D Walker, Joyce A Benjamins, et al.
Neuroscience Letters|September 1, 2004
Microglial activation is a pharmacologically specific marker for the neurotoxic amphetaminesDavid M Thomas, Jennifer Dowgiert, Timothy J Geddes, et al.
Journal of Neurochemistry|August 21, 2010
The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatumDavid M Thomas, Mariana Angoa Pérez, Dina M Francescutti-Verbeem, et al.
Pageof 22

Showing results (61-70 of 217) with videos related to

Sort By:
Pageof 22
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2021
Germline PALB2 Variants and PARP Inhibitors in Endometrial CancerMichael A Cilento, Nicola K Poplawski, Sellvakumaram Paramasivam, et al.
Cancer Metastasis Reviews|September 11, 2007
RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancerJonathan C M Clark, David M Thomas, Peter F M Choong, et al.
Inhalation Toxicology|January 9, 2013
Tobacco smoke modulates ozone-induced toxicity in rat lungs and central nervous systemVanitha Bhoopalan, Sung Gu Han, Mrudang M Shah, et al.
Pharmacology & Therapeutics|August 22, 2012
Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcomaFergal C Kelleher, Jason E Cain, Joan M Healy, et al.
Oncoimmunology|December 18, 2012
Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcomaChristophe Paget, Helene Duret, Shin Foong Ngiow, et al.
Clinical Sarcoma Research|December 11, 2013
Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective reviewJeremy Lewin, Samantha Wieringa, Marnie Collins, et al.
Asia-Pacific Journal of Clinical Oncology|March 1, 2016
International survey of awareness of genetic risk in the clinical sarcoma communityKate A McBride, Timothy E Schlub, Mandy L Ballinger, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 28, 2004
Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activationDavid M Thomas, Paul D Walker, Joyce A Benjamins, et al.
Neuroscience Letters|September 1, 2004
Microglial activation is a pharmacologically specific marker for the neurotoxic amphetaminesDavid M Thomas, Jennifer Dowgiert, Timothy J Geddes, et al.
Journal of Neurochemistry|August 21, 2010
The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatumDavid M Thomas, Mariana Angoa Pérez, Dina M Francescutti-Verbeem, et al.
Pageof 22